Establishment Labs Holdings Inc. (ESTA)

USD 27.31

(-12.75%)

Market Cap (In USD)

787.77 Million

Revenue (In USD)

165.15 Million

Net Income (In USD)

-78.5 Million

Avg. Volume

653.4 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
23.38-60.12
PE
-9.1
EPS
-3.0
Beta Value
1.208
ISIN
VGG312491084
CUSIP
G31249108
CIK
1688757
Shares
28845800.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Juan Jose Chacon Quiros
Employee Count
-
Website
https://www.establishmentlabs.com
Ipo Date
2018-07-19
Details
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.